These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignancies. Schiff JP; Mahmood M; Huang Y; Powell MA; Mutch D; Dyk PT; Lin AJ; Schwarz JK; Markovina ST; Grigsby PW Gynecol Oncol; 2022 Jun; 165(3):486-492. PubMed ID: 35370010 [TBL] [Abstract][Full Text] [Related]
6. Inversely and adaptively planned interstitial brachytherapy: A single implant approach. Hanania AN; Myers P; Yoder AK; Bulut A; Henry Yu Z; Eraj S; Bowers J; Bonnen MD; Echeverria A; Hall TR; Anderson ML; Ludwig M Gynecol Oncol; 2019 Feb; 152(2):353-360. PubMed ID: 30449720 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of freehand interstitial brachytherapy in advanced gynecologic malignancies. Bajwa HK; Singareddy R; Krishnam Raju A Brachytherapy; 2020; 19(5):669-673. PubMed ID: 32466952 [TBL] [Abstract][Full Text] [Related]
8. Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies. Murakami N; Kasamatsu T; Sumi M; Yoshimura R; Harada K; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Itami J Radiat Oncol; 2014 Jan; 9():31. PubMed ID: 24456669 [TBL] [Abstract][Full Text] [Related]
9. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies. Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355 [TBL] [Abstract][Full Text] [Related]
10. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience. Mahantshetty U; Shrivastava S; Kalyani N; Banerjee S; Engineer R; Chopra S Brachytherapy; 2014; 13(4):337-42. PubMed ID: 24176863 [TBL] [Abstract][Full Text] [Related]
11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
12. Salvage Re-irradiation With Single-modality Interstitial Brachytherapy for the Treatment of Recurrent Gynaecological Tumours in the Pelvis: A Multi-institutional Study. Raziee H; D'Souza D; Velker V; Barnes E; Taggar A; Mendez L; Leung E Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):43-51. PubMed ID: 31402286 [TBL] [Abstract][Full Text] [Related]
13. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer. Lee LJ; Viswanathan AN Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: A single institutional experience. Mahantshetty U; Naga P; Engineer R; Sastri S; Ghadi Y; Upreti U; Somesan V; Kadam S; Kohle S; Deshpande D; Shrivastava SK Brachytherapy; 2017; 16(1):153-160. PubMed ID: 27876410 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance. Lee LJ; Damato AL; Viswanathan AN Brachytherapy; 2013; 12(4):303-10. PubMed ID: 23491023 [TBL] [Abstract][Full Text] [Related]
16. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies. Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793 [TBL] [Abstract][Full Text] [Related]
17. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT). Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469 [TBL] [Abstract][Full Text] [Related]